Home › Focal Segmental Glomerulosclerosis › Texas › Dallas
Focal Segmental Glomerulosclerosis clinical trials in Dallas, TX
4 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around Dallas (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
RecruitingPhase 2
- Renal Disease Research Institute - Dallas - Live Oak Street- Site Number : 8400024, Dallas
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 3
- Advanced Dallas Hospital and Clinics, Dallas
- Nephrotex Research Group, Dallas
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 2
- Investigator Site #21, Dallas
- Investigator Site #9, Dallas
Nephrotic Syndrome Study Network
RecruitingObservational study
- University of Texas-Southwestern, Dallas
Focal Segmental Glomerulosclerosis trials in other cities
- Philadelphia, PA9 studies
- Durham, NC8 studies
- New York City, NY7 studies
- Miami, FL6 studies
- Queens, NY6 studies
- Los Angeles, CA6 studies
- Ann Arbor, MI6 studies
- Atlanta, GA5 studies
- Houston, TX5 studies
- Kansas City, MO4 studies
- Cleveland, OH4 studies
- Chicago, IL4 studies
Other studies in Dallas
- Breast Cancer54 studies
- Non-Small Cell Lung Cancer52 studies
- Heart Failure43 studies
- Metastatic Cancer42 studies
- Cancer (all types)38 studies
- Prostate Cancer36 studies
- Colorectal Cancer33 studies
- Obesity31 studies
- Ovarian Cancer28 studies
- Bladder Cancer27 studies
- Lung Cancer27 studies
- Endometrial Cancer25 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.